Technical analysis of AIM ImmunoTech Inc. (AIM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States.
Price Performance
| 1 month | -9.36% |
| 3 months | -44.20% |
| Year-to-date | -81.24% |
| 1 year | -91.17% |
| 3 years | -99.63% |
| 5 years | -99.89% |
52-Week Range
| 52-week High | $2.80 |
| 52-week Low | $0.19 |
| Avg Volume (90d) | 22.1M |
Technical Indicators
| SMA 50 | $0.25 |
| SMA 200 | $0.68 |
| Beta | 1.36 |
| 30-day Volatility (annualised) | 84.4% |
| Price vs SMA 50 | -15.1% |
| Price vs SMA 200 | -68.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.98 | |
| 2025-11 | $1.52 | -23.2% |
| 2025-12 | $1.13 | -25.7% |
| 2026-01 | $1.15 | +1.8% |
| 2026-02 | $0.91 | -21.1% |
| 2026-03 | $0.58 | -35.5% |
| 2026-04 | $0.52 | -11.4% |
| 2026-05 | $0.41 | -21.4% |
| 2026-06 | $0.28 | -30.4% |
| 2026-07 | $0.25 | -10.7% |
| 2026-08 | $0.23 | -10.9% |
| 2026-09 | $0.21 | -6.2% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.21 |
| Market Cap | $1M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 0.46 |
| EV / EBITDA | 0.40 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.51 |
| Current Ratio | 2.11 |